HomeDXCM • NASDAQ
add
DexCom Inc
Previous close
$80.09
Day range
$76.86 - $79.64
Year range
$62.34 - $142.00
Market cap
30.37B USD
Avg Volume
3.17M
P/E ratio
47.47
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 994.20M | 1.97% |
Operating expense | 441.80M | 5.74% |
Net income | 134.60M | 11.52% |
Net profit margin | 13.54 | 9.37% |
Earnings per share | 0.45 | -10.00% |
EBITDA | 207.30M | -18.29% |
Effective tax rate | 24.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.49B | -23.08% |
Total assets | 6.35B | -3.67% |
Total liabilities | 4.37B | 1.07% |
Total equity | 1.98B | — |
Shares outstanding | 390.60M | — |
Price to book | 15.80 | — |
Return on assets | 5.78% | — |
Return on capital | 7.92% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 134.60M | 11.52% |
Cash from operations | 199.50M | -25.89% |
Cash from investing | 210.30M | 217.16% |
Cash from financing | -736.50M | -15.55% |
Net change in cash | -318.10M | 42.29% |
Free cash flow | 48.36M | -85.35% |
About
DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland. Wikipedia
Founded
1999
Headquarters
Website
Employees
9,550
